IL166484A0 - Myriaporone derivatives - Google Patents
Myriaporone derivativesInfo
- Publication number
- IL166484A0 IL166484A0 IL16648405A IL16648405A IL166484A0 IL 166484 A0 IL166484 A0 IL 166484A0 IL 16648405 A IL16648405 A IL 16648405A IL 16648405 A IL16648405 A IL 16648405A IL 166484 A0 IL166484 A0 IL 166484A0
- Authority
- IL
- Israel
- Prior art keywords
- substituted
- unsubstituted
- group
- aralkyl
- aryl
- Prior art date
Links
- 125000003342 alkenyl group Chemical group 0.000 abstract 3
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 125000000304 alkynyl group Chemical group 0.000 abstract 3
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 3
- 125000003118 aryl group Chemical group 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 3
- 125000001072 heteroaryl group Chemical group 0.000 abstract 2
- 229910006080 SO2X Inorganic materials 0.000 abstract 1
- 125000001118 alkylidene group Chemical group 0.000 abstract 1
- 125000004103 aminoalkyl group Chemical group 0.000 abstract 1
- 230000000259 anti-tumor effect Effects 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 229940125904 compound 1 Drugs 0.000 abstract 1
- 229940126214 compound 3 Drugs 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 125000001188 haloalkyl group Chemical group 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 229940002612 prodrug Drugs 0.000 abstract 1
- 239000000651 prodrug Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
- C07D303/32—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by aldehydo- or ketonic radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/08—Bridged systems
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Epoxy Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Steroid Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines Containing Plant Substances (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0217638.6A GB0217638D0 (en) | 2002-07-30 | 2002-07-30 | Total synthesis of myriaporones |
| PCT/GB2003/003327 WO2004011458A1 (en) | 2002-07-30 | 2003-07-30 | Total synthesis of myriaporones |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL166484A0 true IL166484A0 (en) | 2006-01-15 |
Family
ID=9941374
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL16648405A IL166484A0 (en) | 2002-07-30 | 2005-01-25 | Myriaporone derivatives |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US7521478B2 (de) |
| EP (1) | EP1532139B1 (de) |
| JP (1) | JP2006504659A (de) |
| KR (1) | KR20050053599A (de) |
| CN (1) | CN100390167C (de) |
| AT (1) | ATE364603T1 (de) |
| AU (1) | AU2003248984A1 (de) |
| CA (1) | CA2494532A1 (de) |
| DE (1) | DE60314426T2 (de) |
| DK (1) | DK1532139T3 (de) |
| ES (1) | ES2289337T3 (de) |
| GB (1) | GB0217638D0 (de) |
| IL (1) | IL166484A0 (de) |
| MX (1) | MXPA05001176A (de) |
| NO (1) | NO20051037L (de) |
| NZ (1) | NZ537678A (de) |
| PT (1) | PT1532139E (de) |
| RU (1) | RU2328492C2 (de) |
| SI (1) | SI1532139T1 (de) |
| WO (1) | WO2004011458A1 (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11332480B2 (en) | 2017-04-27 | 2022-05-17 | Pharma Mar, S.A. | Antitumoral compounds |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5514708A (en) * | 1994-02-18 | 1996-05-07 | Pharmamar, S.A. | Cytotoxic metabolites from Myriapora truncata |
| HRP970141A2 (en) * | 1997-03-12 | 1999-02-28 | Banić-Tomaueić Zrinka | New secomacrolydes of erythromicin a, and a process for the preparation thereof |
-
2002
- 2002-07-30 GB GBGB0217638.6A patent/GB0217638D0/en not_active Ceased
-
2003
- 2003-07-30 US US10/523,172 patent/US7521478B2/en not_active Expired - Fee Related
- 2003-07-30 WO PCT/GB2003/003327 patent/WO2004011458A1/en not_active Ceased
- 2003-07-30 KR KR1020057001661A patent/KR20050053599A/ko not_active Ceased
- 2003-07-30 RU RU2005105329/04A patent/RU2328492C2/ru not_active IP Right Cessation
- 2003-07-30 MX MXPA05001176A patent/MXPA05001176A/es active IP Right Grant
- 2003-07-30 PT PT03771210T patent/PT1532139E/pt unknown
- 2003-07-30 DE DE60314426T patent/DE60314426T2/de not_active Expired - Fee Related
- 2003-07-30 AU AU2003248984A patent/AU2003248984A1/en not_active Abandoned
- 2003-07-30 DK DK03771210T patent/DK1532139T3/da active
- 2003-07-30 CA CA002494532A patent/CA2494532A1/en not_active Abandoned
- 2003-07-30 EP EP03771210A patent/EP1532139B1/de not_active Expired - Lifetime
- 2003-07-30 AT AT03771210T patent/ATE364603T1/de not_active IP Right Cessation
- 2003-07-30 SI SI200330909T patent/SI1532139T1/sl unknown
- 2003-07-30 JP JP2004523987A patent/JP2006504659A/ja active Pending
- 2003-07-30 CN CNB038233142A patent/CN100390167C/zh not_active Expired - Fee Related
- 2003-07-30 NZ NZ537678A patent/NZ537678A/en unknown
- 2003-07-30 ES ES03771210T patent/ES2289337T3/es not_active Expired - Lifetime
-
2005
- 2005-01-25 IL IL16648405A patent/IL166484A0/xx unknown
- 2005-02-25 NO NO20051037A patent/NO20051037L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| US20080269511A2 (en) | 2008-10-30 |
| EP1532139A1 (de) | 2005-05-25 |
| EP1532139B1 (de) | 2007-06-13 |
| US20060084819A1 (en) | 2006-04-20 |
| DE60314426D1 (de) | 2007-07-26 |
| RU2005105329A (ru) | 2005-08-27 |
| JP2006504659A (ja) | 2006-02-09 |
| AU2003248984A1 (en) | 2004-02-16 |
| US20080103320A2 (en) | 2008-05-01 |
| DE60314426T2 (de) | 2008-02-14 |
| WO2004011458A1 (en) | 2004-02-05 |
| ATE364603T1 (de) | 2007-07-15 |
| PT1532139E (pt) | 2007-09-20 |
| RU2328492C2 (ru) | 2008-07-10 |
| KR20050053599A (ko) | 2005-06-08 |
| GB0217638D0 (en) | 2002-09-11 |
| CN100390167C (zh) | 2008-05-28 |
| US7521478B2 (en) | 2009-04-21 |
| NO20051037L (no) | 2005-04-13 |
| ES2289337T3 (es) | 2008-02-01 |
| NZ537678A (en) | 2006-11-30 |
| DK1532139T3 (da) | 2007-10-15 |
| MXPA05001176A (es) | 2005-09-12 |
| SI1532139T1 (sl) | 2007-10-31 |
| CN1684956A (zh) | 2005-10-19 |
| CA2494532A1 (en) | 2004-02-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20012617L (no) | Kinolin- og kinzolinderivater | |
| DK0622361T3 (da) | Heterocykliske forbindelser som bradykininantagonister | |
| DK1117297T3 (da) | Syntetiske analoger af ecteinascidin-743 | |
| CY1112899T1 (el) | Παραγωγα θειαδιαζολινης για τη θεραπεια του καρκινου | |
| DK0535231T3 (da) | Pyrimidinnucleosid-derivater | |
| TR200403436T2 (tr) | Kristalin 1-metilkarbapenem türevleri. | |
| DE69617909D1 (de) | 2-substituierte vitamin-d3-derivate | |
| WO2004014917A3 (en) | Antitumoral analogs of lamellarins | |
| MXPA03000341A (es) | Derivados de variolina como agentes anit-cancer. | |
| GB0217638D0 (en) | Total synthesis of myriaporones | |
| PL366894A1 (en) | Variolin derivatives and their use as antitumor agents | |
| ATE552003T1 (de) | Chinoxalinderivate | |
| NO20053302D0 (no) | Imidazolderivater med affinitet for alfa 2-reseptoraktivitet. | |
| ATE316524T1 (de) | Oxy- und aminosubstituierte tetrahydrofurylderivate mit antitumoraktivität | |
| DE60103732D1 (de) | Pyrimidinderivate mit antitumor-wirkung |